Full text is available at the source.
Abstract
HMB treatment significantly improved cell viability, surface area, and fiber diameter in C2C12 myotubes exposed to dexamethasone-induced muscle atrophy.
- HMB reduced the expression of CBL-B, MuRF1, and Atrogin1, which are associated with muscle breakdown.
- Increased myogenin expression was observed with HMB treatment compared to conditions of muscle atrophy.
- HMB treatment did not activate AKT or mTOR, but increased phosphorylation of P70S6K and S6 through a phospholipase D-dependent mechanism.
- HMB restored circadian clock gene expression disrupted by dexamethasone and normalized expression patterns.
- The treatment enhanced circadian rhythmic amplitude and advanced phase timing, indicating improved robustness of the circadian clock.
Simplified